[Effect of Regulating A20 Expression on NF-κB Expression and Biological Characteristics of Jurkat Cells]

Zhe Wang1, Shi-Shan Xiao1, Qian Ding1

  • 1Department of Hematology, Guizhou Provincial People's Hospital, Guiyang 550002, Guizhou Province, China.

Abstract

Insights

Overexpressing A20 enhances glucocorticoid (GC) sensitivity in resistant Jurkat cells. This approach reduces cell proliferation, lowers NF-κB expression, and promotes apoptosis, offering a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Glucocorticoid (GC) resistance is a significant challenge in treating certain leukemias, necessitating novel therapeutic strategies.
  • The NF-κB signaling pathway plays a crucial role in cell survival and resistance to apoptosis, often implicated in GC resistance.
  • A20 is a key negative regulator of NF-κB signaling, suggesting its potential role in modulating GC sensitivity.

Purpose of the Study:

  • To investigate the impact of regulating A20 expression on the biological characteristics of Jurkat cells exhibiting glucocorticoid resistance.
  • To determine the effect of A20 modulation on NF-κB signaling pathway activation in these resistant cells.

Main Methods:

  • Jurkat and CCRF CEM cells were exposed to varying concentrations of dexamethasone (DEX) over different time points.
  • Cell proliferation was assessed using the CCK-8 assay.
  • A20 expression was manipulated by transfecting cells with an A20 plasmid (overexpression) or A20-siRNA (knockdown).
  • NF-κB mRNA and protein levels were quantified using RT-qPCR and Western blot, respectively.
  • Apoptosis was analyzed by flow cytometry.

Main Results:

  • Dexamethasone exhibited time- and concentration-dependent inhibition of CCRF CEM cell growth, with an IC50 around 1 μmol/L at 24 hours.
  • Jurkat cells demonstrated resistance to DEX at 1 μmol/L.
  • Overexpression of A20 in Jurkat cells, in combination with DEX, significantly reduced cell proliferation compared to DEX alone or A20-siRNA treatment.
  • A20 overexpression led to a significant decrease in NF-κB expression and a significant increase in apoptosis.
  • A20-siRNA treatment resulted in a significant increase in NF-κB expression without significantly altering apoptosis.

Conclusions:

  • Jurkat cells exhibit resistance to dexamethasone.
  • A20 overexpression, coupled with DEX, enhances the sensitivity of GC-resistant Jurkat cells.
  • This combined approach effectively reduces cell proliferation, downregulates NF-κB expression, and promotes apoptosis in Jurkat cells.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.2K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K